6 Related NICE guidance
Published
-
Erlotinib for the treatment of non-small-cell lung cancer.NICE technology appraisal guidance 162 (2008).
-
Bevacizumab for the treatment of non-small-cell lung cancer (terminated appraisal).NICE technology appraisal 148 (2008).
-
Pemetrexed for the treatment of non-small-cell lung cancer.NICE technology appraisal guidance 124 (2007).
-
Lung cancer: the diagnosis and treatment of lung cancer. NICE clinical guideline 24 (2005). [Replaced by NICE clinical guideline 121]
-
Gefitinib for the first-line treatment of locally advanced or metastatic non-small-cell lung cancer. NICE technology appraisal guidance 192 (2010)
-
Erlotinib monotherapy for maintenance treatment of non-small-cell lung cancer. NICE technology appraisal guidance 227 (2011).
Under development
NICE is developing the following guidance(details available from the NICE website):
-
Cetuximab for the treatment of advanced non-small-cell lung cancer. NICE technology appraisal guidance(publication date to be confirmed).